Brigit Biofarmaka Teknologi Tbk. vs Sumber Mineral Global Abadi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Sumber Mineral Global Abadi Tbk. trades at Rp76 (market cap 638.75B, 21.58M 24h volume). The key difference: Sumber Mineral Global Abadi Tbk. is far larger — about 3.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sumber Mineral Global Abadi Tbk. is more actively traded (21.58M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SMGA | |
|---|---|---|
Market Cap | 172.82B | 638.75B |
Volume | 592.2K | 21.58M |
Lot | 5.92K | 215.82K |
Turnover | 147.05M | 1.58B |
Average Price | 248.31 | 73.21 |
Value | 147.05M | 1.58B |
Indicative Equilibrium Price | 254 | 76 |
Indicative Equilibrium Volume | 10 | 12.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Sumber Mineral Global Abadi Tbk (the Company) was established based on Notarial Deed No. 2 dated October 19, 2016 of Selina Bertha Eny, S.H., a notary in South Tanggerang. The Company started its commercial operations in 2016. The Company’s immediate and ultimate parententities are PT Sumber Global Energy Tbk and PT Sumbermas Inti Energi, respectively, both entities domiciled in Jakarta. The controlling interest of the Company is PT Sumber Global Energy Tbk.
Read more on SMGA →